A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
- Status
- COMPLETED
- Phase
- PHASE2
Managed Access Program for Combination Treatment With Belantamab Mafodotin in Multiple Myeloma
- Status
- AVAILABLE
- Phase
- N/A
Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CURATE.AI Optimized Modulation for Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Ixazomib -Daratumumab Without Dexamethasone (IDara) in Elderly Relapse Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety Evaluation of BCMA-UCART
- Status
- SUSPENDED
- Phase
- NA
Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Daratumumab in Combination With Ixazomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Evaluation of Pharmacokinetics, Safety, and Preliminary Efficacy of Isatuximab in Chinese Patients With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Expanded Access for CC-4047
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
Registry for Adults With Plasma Cell Disorders (PCD's)
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1